ELOC mutant renal cell carcinoma
Conditions
Interventions
Gold Standard:Sanger sequencing or whole exon sequencing
Index test:CK, CA9, PAX8, ELOC gene mutation
Sponsors
The First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Pathologically diagnosed as clear cell renal cell carcinoma with obvious fibromuscular septum and CK7 positive (to be clearly classified); 2. Pathological diagnosis was considered as clear cell papillary renal cell tumor (undiagnosed); 3. Have complete clinical pathology information;
Exclusion criteria
Exclusion criteria: 1.A clear diagnosis was clear cell renal cell carcinoma, papillary renal cell carcinoma, and other renal cell carcinoma with clear molecular changes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-Free Survival;Overall Survival;Accuracy;Sensitivity;Specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| ELOC gene mutation; | — |
Countries
China
Contacts
Public ContactGuang-Jie Duan
The First Affiliated Hospital of Army Medical University
Outcome results
None listed